Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06775925

Robot-assisted Vs. Conventional Occupational Therapy of the Upper Limb in Individuals with Cervical Spinal Cord Injury

Led by Swiss Paraplegic Research, Nottwil · Updated on 2025-03-10

40

Participants Needed

1

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn the effects of robot-assisted therapy using the ArmeoSpring on upper limb function compared to conventional occupational therpay in individuals with cervical spinal cord injury (cSCI). The main questions it aims to answer are: \- Which of the two forms of therapy, robot-assisted therapy or conventional occupational therapy, is more effective in terms of improving arm and hand function? The study is designed as a cross-over trial, which means that each participant will receive both therapy forms consecutively, whereas the order is assigned randomly (either robot-assisted therapy first and then occupational therapy, or vice versa). In addition to their clinical routine therapy , participants will: * complete a baseline assessment * practice one therapy form (either robot-assisted or occupational therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a intermediate assessment * practice the other therapy form (either occupational or robot-assisted therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a post assessment * complete a follow-up assessment (if the post assessment was completed prior to 150 days post-injury)

CONDITIONS

Official Title

Robot-assisted Vs. Conventional Occupational Therapy of the Upper Limb in Individuals with Cervical Spinal Cord Injury

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • Traumatic or non-traumatic cervical spinal cord injury between more than 16 days and 81 days post-injury during primary rehabilitation at the Swiss Paraplegic Centre
  • Neurological injury level between C1 and T1
  • American Spinal Injury Association Impairment Scale (AIS) grade A to D
  • Upper limb function impairment with GRASSP-QtG score unilateral less than 25 at baseline
  • Ability to sit for 60 minutes and perform training with ArmeoSpring
  • Stratification parameters available
Not Eligible

You will not qualify if you...

  • Unable to follow study procedures
  • Severe additional neurological disease
  • Neurodegenerative or progressive diseases
  • Upper limb function impairment due to peripheral nerve lesions
  • Severe other medical disease or conditions that could affect study results
  • Orthopedic limitations of the upper limb
  • Contraindications specific to the device
  • Participation in other interventional trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Swiss Paraplegic Centre

Nottwil, Canton of Lucerne, Switzerland, 6207

Actively Recruiting

Loading map...

Research Team

M

Mario Widmer, Dr. sc. ETH

CONTACT

C

Chantal Wunderlin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here